Canon places fifth in United States patent rankings and first among Japanese companies, places in top five for 38 years running

Canon Inc. (www.Canon-CNA.com) ranked fifth for the number of U.S. patents awarded in 2023, becoming the only company in the world to have ranked in the top five for 38 years running, according to the latest ranking of preliminary patent results issued by IFI CLAIMS Patent Services.

What’s more, Canon ranked first among Japanese companies for 19 consecutive years. Canon actively promotes the globalization of its business and places great value on obtaining patents overseas, carefully adhering to a patent-filing strategy that pursues patents in essential countries and regions while taking into consideration the business strategies and technology and product trends unique to each location.

Among these, the United States, with its many high-tech companies and large market scale, represents a particularly important region in terms of business expansion and technology alliances.

Canon aims to create new technologies in its four business groups of Printing, Imaging, Medical and Industrial Equipment. In addition to strengthening the competitiveness of each of its businesses, in recent years, the company has been focusing on the development of fundamental technologies such as cutting-edge SPAD sensors, photon counting CT, image processing technology that utilizes deep learning, next-generation technology for commercial printing, and nanoimprint lithography, that can be the source of business creation, being applied and utilized for various purposes, as well as the acquisition of patent rights for such technologies.

In keeping with the times, in order to encourage the core competency technologies that support its business, Canon promotes the acquisition and utilization of intellectual property rights which it uses to maintain a robust patent portfolio that ensures the competitiveness and freedom of its businesses.

Going forward, Canon will continue its intellectual property initiatives with the goal of supporting its businesses, providing products and services with added value, and contributing to a better society.

Distributed by APO Group on behalf of Canon Central and North Africa (CCNA).

Media enquiries, please contact:
Canon Central and North Africa
Mai Youssef
e. Mai.youssef@canon-me.com

APO Group – PR Agency
Rania ElRafie
e. Rania.ElRafie@apo-opa.com

About Canon Central and North Africa:
Canon Central and North Africa (CCNA) (www.Canon-CNA.com) is a division within Canon Middle East FZ LLC (CME), a subsidiary of Canon Europe. The formation of CCNA in 2016 was a strategic step that aimed to enhance Canon’s business within the Africa region – by strengthening Canon’s in-country presence and focus. CCNA also demonstrates Canon’s commitment to operating closer to its customers and meeting their demands in the rapidly evolving African market.

Canon has been represented in the African continent for more than 15 years through distributors and partners that have successfully built a solid customer base in the region. CCNA ensures the provision of high quality, technologically advanced products that meet the requirements of Africa’s rapidly evolving marketplace. With over 100 employees, CCNA manages sales and marketing activities across 44 countries in Africa.

Canon’s corporate philosophy is Kyosei (https://apo-opa.co/3SvVhrS) – ‘living and working together for the common good’. CCNA pursues sustainable business growth, focusing on reducing its own environmental impact and supporting customers to reduce theirs using Canon’s products, solutions and services. At Canon, we are pioneers, constantly redefining the world of imaging for the greater good. Through our technology and our spirit of innovation, we push the bounds of what is possible – helping us to see our world in ways we never have before. We help bring creativity to life, one image at a time. Because when we can see our world, we can transform it for the better.

For more information: www.Canon-CNA.com

Media files

Download logo

Source: Apo-Opa

Did you find this information helpful? If you did, consider donating.